These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 20172070)

  • 61. Fluorescein angiography as a primary guide for reduced-fluence photodynamic therapy for the treatment of chronic central serous chorioretinopathy.
    Koytak A; Bayraktar H; Ozdemir H
    Int Ophthalmol; 2020 Jul; 40(7):1807-1813. PubMed ID: 32274613
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Long-Term Efficacy and Safety of Photodynamic Therapy in Patients With Chronic Central Serous Chorioretinopathy.
    Park YJ; Kim YK; Park KH; Woo SJ
    Ophthalmic Surg Lasers Imaging Retina; 2019 Dec; 50(12):760-770. PubMed ID: 31877221
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Long-term follow-up of standard photodynamic therapy with standardized small spot size for diffuse retinal pigment epitheliopathy.
    Rouvas A; Nikita E; Chatziralli I; Ladas I; Androu A; Theodossiadis P
    Eur J Ophthalmol; 2015; 25(3):229-34. PubMed ID: 25449640
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison of the fluorescein angiography-guided and indocyanine green angiography-guided photodynamic therapy in the treatment of non-resolving central serous chorioretinopathy.
    Ebrahimiadib N; Mirzaei A; Esfandiarifard S; Tuli S; Najibzadeh E; Imani Fooladi M; Fadakar K
    Sci Rep; 2023 Jan; 13(1):1682. PubMed ID: 36717729
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of photodynamic therapy on short-wavelength fundus autofluorescence in eyes with acute central serous chorioretinopathy.
    Hagen S; Ansari-Shahrezaei S; Smretschnig E; Glittenberg C; Krebs I; Steiner I; Binder S
    Retina; 2015 Feb; 35(2):223-30. PubMed ID: 25102195
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Photodynamic therapy for treatment of chronic or recurrent central serous chorioretinopathy].
    Li L; Yuan F; Xu GZ; Wang WJ
    Zhonghua Yan Ke Za Zhi; 2012 Feb; 48(2):106-13. PubMed ID: 22490944
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Early visual and morphologic changes after half-fluence photodynamic therapy in chronic central serous chorioretinopathy.
    Alkin Z; Ozkaya A; Agca A; Yazici AT; Demirok A
    J Ocul Pharmacol Ther; 2014 May; 30(4):359-65. PubMed ID: 24456481
    [TBL] [Abstract][Full Text] [Related]  

  • 68. One-year choroidal thickness results after photodynamic therapy for central serous chorioretinopathy.
    Maruko I; Iida T; Sugano Y; Furuta M; Sekiryu T
    Retina; 2011 Oct; 31(9):1921-7. PubMed ID: 21878850
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Correlation of integrity of cone outer segment tips line with retinal sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy.
    Fujita K; Shinoda K; Imamura Y; Matsumoto CS; Mizutani Y; Mizota A; Yuzawa M
    Am J Ophthalmol; 2012 Sep; 154(3):579-85. PubMed ID: 22818904
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Choroidal thickness after half-dose verteporfin photodynamic therapy in chronic central serous chorioretinopathy].
    Zeng J; Yan YY; Ding XY; Liu R; Li JQ
    Zhonghua Yan Ke Za Zhi; 2013 Jun; 49(6):490-4. PubMed ID: 24119960
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy: one-year results of a prospective study.
    Chan WM; Lai TY; Lai RY; Tang EW; Liu DT; Lam DS
    Retina; 2008 Jan; 28(1):85-93. PubMed ID: 18185143
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Quantitative Evaluation of Retinal Vessel Density in Central Serous Chorioretinopathy after Half-dose Photodynamic Therapy.
    Xu F; Zhou L; Lai K; Gong Y; Li L; Lian P; Huang C; Ding X; Lu L; Jin C
    Curr Eye Res; 2021 Jun; 46(6):855-864. PubMed ID: 33141608
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. 2003.
    Yannuzzi LA; Slakter JS; Gross NE; Spaide RF; Costa DL; Huang SJ; Klancnik JM; Aizman A
    Retina; 2012 Feb; 32 Suppl 1():288-98. PubMed ID: 22451952
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Photodynamic therapy for steroid-associated central serous chorioretinopathy.
    Lee TG; Kim JE
    Br J Ophthalmol; 2011 Apr; 95(4):518-23. PubMed ID: 20679080
    [TBL] [Abstract][Full Text] [Related]  

  • 75. One-year results of half-dose versus one-third-dose photodynamic therapy in chronic or recurrent central serous chorioretinopathy.
    Pichai J; Vanchalerm B; Mansing R
    BMC Ophthalmol; 2021 Jan; 21(1):30. PubMed ID: 33430812
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Photodynamic therapy in a patient with chronic central serous chorioretinopathy--a case report].
    Pociej W; Karska-Basta I; Kolár L; Oleksy P; Romanowska-Dixon B
    Klin Oczna; 2014; 116(1):28-31. PubMed ID: 25137918
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Low-fluence photodynamic therapy in longstanding chronic central serous chorioretinopathy with foveal and gravitational atrophy.
    Reibaldi M; Boscia F; Avitabile T; Russo A; Cannemi V; Uva MG; Reibaldi A
    Eur J Ophthalmol; 2009; 19(1):154-8. PubMed ID: 19123167
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Long-term follow-up of photoreceptor loss and recovery after half-fluence photodynamic therapy for chronic central serous chorioretinopathy.
    Gutiérrez-Hernández JC; Martínez-Camarillo JC; Sadda SR
    Retin Cases Brief Rep; 2015; 9(2):109-13. PubMed ID: 25383847
    [TBL] [Abstract][Full Text] [Related]  

  • 79. SAFETY AND EFFICACY OF PHOTODYNAMIC THERAPY WITH CHLORIN E6 IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
    Maltsev DS; Kulikov AN; Vasiliev AS; Chhablani J
    Retina; 2024 Aug; 44(8):1387-1393. PubMed ID: 38484089
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Considering photodynamic therapy as a therapeutic modality in selected cases of dome-shaped macula complicated by foveal serous retinal detachment.
    Arapi I; Neri P; Mariotti C; Gesuita R; Pirani V; Freddo F; Lutaj P; Giovannini A
    Ophthalmic Surg Lasers Imaging Retina; 2015 Feb; 46(2):217-23. PubMed ID: 25707047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.